Star Combo Pharma Ltd (S66) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.015x

Based on the latest financial reports, Star Combo Pharma Ltd (S66) has a cash flow conversion efficiency ratio of 0.015x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$575.23K ≈ $407.01K USD) by net assets (AU$38.68 Million ≈ $27.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Star Combo Pharma Ltd market capitalisation for the company's overall valuation and market capitalisation.

Star Combo Pharma Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Star Combo Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Star Combo Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Star Combo Pharma Ltd ranked by their cash flow conversion efficiency. Explore Star Combo Pharma Ltd (S66) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
AroCell AB
ST:AROC
-0.010x
Radius Gold Inc.
V:RDU
-0.098x
Terragen Holdings Ltd
AU:TGH
-0.330x
Serica Energy PLC
LSE:SQZ
0.080x
Mynd.ai, Inc.
NYSE MKT:MYND
-0.360x
Vertex Resource Group Ltd
V:VTX
0.187x
Future Retail Limited
NSE:FRETAIL
1.043x
Yong Tai Bhd
KLSE:7066
0.005x

Annual Cash Flow Conversion Efficiency for Star Combo Pharma Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025. View S66 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$38.26 Million
≈ $27.07 Million
AU$11.94 Million
≈ $8.45 Million
0.312x +3404.96%
2024-06-30 AU$33.51 Million
≈ $23.71 Million
AU$-316.45K
≈ $-223.91K
-0.009x -116.74%
2023-06-30 AU$33.26 Million
≈ $23.53 Million
AU$1.88 Million
≈ $1.33 Million
0.056x +2193.37%
2022-06-30 AU$35.41 Million
≈ $25.05 Million
AU$87.11K
≈ $61.64K
0.002x -73.14%
2021-06-30 AU$36.19 Million
≈ $25.61 Million
AU$331.53K
≈ $234.58K
0.009x +140.03%
2020-06-30 AU$44.50 Million
≈ $31.49 Million
AU$-1.02 Million
≈ $-720.42K
-0.023x +79.06%
2019-06-30 AU$20.00 Million
≈ $14.15 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.109x +3.35%
2018-06-30 AU$16.26 Million
≈ $11.50 Million
AU$-1.84 Million
≈ $-1.30 Million
-0.113x -290.16%
2017-06-30 AU$15.68 Million
≈ $11.10 Million
AU$932.20K
≈ $659.59K
0.059x -82.19%
2016-06-30 AU$3.88 Million
≈ $2.75 Million
AU$1.30 Million
≈ $917.50K
0.334x --

About Star Combo Pharma Ltd

AU:S66 Australia Household & Personal Products
Market Cap
$13.38 Million
AU$18.91 Million AUD
Market Cap Rank
#26410 Global
#1198 in Australia
Share Price
AU$0.14
Change (1 day)
+0.00%
52-Week Range
AU$0.11 - AU$0.27
All Time High
AU$1.72
About

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more